Retracted: Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c

Current treatments for breast cancer, a common malignancy in human females, are less than satisfactory because of high rates of metastasis. Glabridin (GLA), which acts through the FAK/ROS signaling pathway, has been used as an antioxidant and anti-metastatic agent. However, little is known regarding...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Xianqing, Jiang, Fei, Li, Yuan, Mu, Juan, Si, Lu, Wang, Xingxing, Ning, Shilong, Li, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
This Article Has Been Retracted
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317926/
https://www.ncbi.nlm.nih.gov/pubmed/24754877
http://dx.doi.org/10.1111/cas.12426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317926/
https://www.ncbi.nlm.nih.gov/pubmed/24754877
http://dx.doi.org/10.1111/cas.12426

Ejemplares similares